(Q30470326)

26 September 2017

Hearing in adults with Pompe disease (English)

1 reference

26 September 2017

5

Pieter A van Doorn

1 reference

26 September 2017

Nadine A M E van der Beek

1

1 reference

26 September 2017

Hans Verschuure

2

1 reference

26 September 2017

Arnold J J Reuser

3

1 reference

26 September 2017

Ans T van der Ploeg

4

1 reference

26 September 2017

René M L Poublon

6

1 reference

26 September 2017

15 October 2011

1 reference

Journal of Inherited Metabolic Disease

26 September 2017

1 reference

26 September 2017

35

1 reference

26 September 2017

2

1 reference

26 September 2017

335-341

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-011-9396-3

26 September 2017

0 references

cites work

Hearing loss in Pompe disease revisited: results from a study of 24 children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

A randomized study of alglucosidase alfa in late-onset Pompe's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Ear symptoms in children with Fabry disease: data from the Fabry Outcome Survey

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Hearing loss in Fabry disease: data from the Fabry Outcome Survey.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

ABR and temporal bone pathology in Hurler's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

The Prevalence of Hearing Impairment and Reported Hearing Disability among Adults in Great Britain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Otologic histopathology of Fabry's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Audiometric abnormalities in children with Gaucher disease type 3.

20 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

A model of neuronopathic Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

Prevalence of hearing impairment in a population in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

CRIM-negative infantile Pompe disease: 42-month treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

The epidemiology of hearing impairment in an Australian adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9396-3

Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Hearing loss in Hunter's syndrome--mucopolysaccharidosis II.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278617

Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22002441

12 December 2020

inferred from PubMed ID database lookup

Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22002441

12 December 2020

inferred from PubMed ID database lookup

Clinical features of late-onset Pompe disease: a prospective cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22002441

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10545-011-9396-3

1 reference

Dimensions Publication ID

26 September 2017

1000515096

0 references

Fatcat ID

release_gryxhoaagbd2zkf7g5pcsnnt7i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gryxhoaagbd2zkf7g5pcsnnt7i

24 November 2022

mapped directly with Wikidata item

1 reference

26 September 2017

PubMed publication ID

22002441

1 reference